Algernon Pharmaceuticals Announces Plans for a 180 Patient

Ifenprodil Represents a Novel First-in-Class Potential Treatment for Chronic Cough...

Related Keywords

United States ,Canada ,United Kingdom ,Manchester ,Vancouver ,British Columbia ,British ,Canadian ,Christopherj Moreau ,Jacky Smith ,Company Phase ,Honorary Consultant At Manchester University ,Algernon Pharmaceuticals ,University Of Manchester ,Drug Administration ,Merck Co ,Algernon Pharmaceuticals Inc ,Afferent Pharmaceuticals ,Bellus Health ,While The Company ,Market Research ,Respiratory Medicine ,Honorary Consultant ,Manchester University ,Idiopathic Pulmonary Fibrosis ,Investigational New Drug ,Data Bridge Market Research ,Algernon Neuroscience ,Canadian Stock Exchange Agn Cn ,